Counting the cost of public and philanthropic R

Overview of attention for article published in Journal of Pharmaceutical Policy and Practice, August 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (59th percentile)
Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

twitter: 4 X users

Citations

dimensions_citation: 1 Dimensions

Readers on

mendeley: 14 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 41,807 followers.

RT @alimully: "the public pays twice for pharmaceuticals—once when basic research is funded by the public sector, and then again when high…

12 Apr 2023

Reply Repost Favourite

A great piece here about how the pharmaceutical industry works! No wonder our nation is getting sicker and poorer.

12 Apr 2023

Reply Repost Favourite

"the public pays twice for pharmaceuticals—once when basic research is funded by the public sector, and then again when high prices are paid by governments and individuals for the resulting products" @christheeagle1 https://t.co/sIlzMXF0j6

12 Apr 2023

Reply Repost Favourite

New article: Counting the cost of public and philanthropic R&D funding: the case of olaparib https://t.co/vRvvIb5NzY #breastcancer #oncology https://t.co/S5flUMRrQA

17 Aug 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.